The host-targeted antiviral drug Zapnometinib exhibits a high barrier to the development of SARS-CoV-2 resistance. Schreiber A; Rodner F; Oberberg N; Anhlan D; Bletz S; Mellmann A; Planz O; Ludwig S (2024) In: Antiviral Research, 225 Type of Publication: Research article (journal)
Cell-intrinsic genomic reassortment of pandemic H1N1 2009 and Eurasian avian-like swine influenza viruses results in potentially zoonotic variants. Ferrando VA; Friedrich ME; Gandhi S; Mellmann A; Masemann D; Christersson A; Anhlan D; Brunotte L; Stoll M; Harder T; Beer M; Boergeling Y; Ludwig S (2023) In: Emerging Microbes and Infections, 12(1) Type of Publication: Research article (journal)